M1 KLINIKEN AG (M12.DE) Stock Price, Forecast & Analysis
Europe - FRA:M12 - DE000A0STSQ8 - Common Stock
M12.DE Key Statistics, Chart & Performance
The current stock price of M12.DE is 14.7 EUR. In the past month the price decreased by -8.12%. In the past year, price decreased by -10.37%.
M12.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EMEIS.PA | EMEIS SA | N/A | 2.17B | ||
| CLARI.PA | CLARIANE SE | N/A | 1.21B | ||
| GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 986.89M | ||
| RHK.DE | RHOEN-KLINIKUM AG | 21.79 | 816.91M | ||
| GHC.MI | GAROFALO HEALTH CARE SPA | 14.51 | 471.29M | ||
| LNA.PA | LNA SANTE | 11.31 | 258.11M | ||
| MED.DE | MEDICLIN AG | 4.93 | 166.25M | ||
| LIK.DE | LIMES SCHLOSSKLINIKEN AG | 22.08 | 100.34M | ||
| MAK.DE | MATERNUS-KLINIKEN AG | N/A | 23.07M | ||
| EIF.DE | MEDNATION AG | 16 | 9.48M |
Related stock screener links
About M12.DE
Company Profile
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin and currently employs 152 full-time employees. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
Company Info
M1 KLINIKEN AG
Gruenauer Strasse 5
Berlin BERLIN DE
Employees: 152
Phone: 4930347474414
M1 KLINIKEN AG / M12.DE FAQ
Can you describe the business of M1 KLINIKEN AG?
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin and currently employs 152 full-time employees. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
Can you provide the latest stock price for M1 KLINIKEN AG?
The current stock price of M12.DE is 14.7 EUR. The price increased by 2.08% in the last trading session.
Does M1 KLINIKEN AG pay dividends?
M1 KLINIKEN AG (M12.DE) has a dividend yield of 3.48%. The yearly dividend amount is currently 0.
How is the ChartMill rating for M1 KLINIKEN AG?
M12.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the Price/Earnings (PE) ratio of M1 KLINIKEN AG (M12.DE)?
The PE ratio for M1 KLINIKEN AG (M12.DE) is 15.64. This is based on the reported non-GAAP earnings per share of 0.94 and the current share price of 14.7 EUR.
What is the market capitalization of M12 stock?
M1 KLINIKEN AG (M12.DE) has a market capitalization of 288.71M EUR. This makes M12.DE a Micro Cap stock.
Who owns M1 KLINIKEN AG?
You can find the ownership structure of M1 KLINIKEN AG (M12.DE) on the Ownership tab.
M12.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to M12.DE. When comparing the yearly performance of all stocks, M12.DE is a bad performer in the overall market: 77.22% of all stocks are doing better.
M12.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to M12.DE. M12.DE has an excellent financial health rating, but there are some minor concerns on its profitability.
M12.DE Financial Highlights
Over the last trailing twelve months M12.DE reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS increased by 10.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5% | ||
| ROA | 8.73% | ||
| ROE | 15.03% | ||
| Debt/Equity | 0.05 |
M12.DE Forecast & Estimates
8 analysts have analysed M12.DE and the average price target is 27.03 EUR. This implies a price increase of 83.88% is expected in the next year compared to the current price of 14.7.
For the next year, analysts expect an EPS growth of 5.19% and a revenue growth 6.09% for M12.DE